A third case of mammal-to-human transmission of the highly pathogenic H5N1 bird flu virus has been reported in the United States.

Data provide direct evidence that the standard pasteurization methods used by dairy companies are effective in inactivating all tested subtypes of influenza viruses in raw milk.

Findings highlight the need for research on HPAI A(H5N1) virus in dairy production.

With avian Influenza increasing, two European Commission health threat management experts, Francisco Reviriego and Ingrid Keller, explain the risks of its spread in Europe and what the EU is doing to keep people, animals and the environment safe.

Influenza A viruses in swine have considerable genetic diversity and continue to pose a pandemic threat to humans due to a potential lack of population level immunity.

Avian influenza virus continues to pose zoonotic, epizootic, and pandemic threats worldwide, as exemplified by the 2020–23 epizootics of re-emerging H5 genotype avian influenza viruses

the International Health Regulations (IHR) National Focal Point (NFP) for India reported to WHO a case of human infection with avian influenza A(H9N2) virus detected in a child resident of West Bengal state in India.

The United States has the strongest avian influenza surveillance program in the world.

The vaccine is intended for those most exposed to potential transfers of avian influenza from birds or animals, such as poultry farm workers and veterinarians.

This report provides an update to the April 26, 2024, report to include three additional sporadic human cases (1 in Australia and 2 in the United States) and recent activity in the United States.

Finland has become the first country in the EU to vaccinate against the H5N1 avian flu.